GetTopicDetailResponse(id=cbb816545ca, topicName=somatrogon, introduction=somatrogon, content=null, image=null, comments=4, allHits=987, url=https://h5.medsci.cn/topic?id=16545, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=78739, tagList=[TagDto(tagId=78739, tagName=somatrogon)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1946202, encodeId=762f19462028c, content=<a href='/topic/show?id=cbb816545ca' target=_blank style='color:#2F92EE;'>#somatrogon#</a>, objectTitle=針對生長激素缺乏癥（GHD），F(xiàn)DA為Somatrogon發(fā)出了完整的回復(fù)信（CRL）, objectType=article, longId=294566, objectId=8e112945669d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e112945669d, replyNumber=0, likeNumber=96, createdTime=2022-08-26, rootId=0, userName=12498484m46(暫無昵稱), userId=7e622500011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e112945669d, moduleTitle=針對生長激素缺乏癥（GHD），F(xiàn)DA為Somatrogon發(fā)出了完整的回復(fù)信（CRL）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8e112945669d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946201, encodeId=97ff19462015f, content=<a href='/topic/show?id=cbb816545ca' target=_blank style='color:#2F92EE;'>#somatrogon#</a>, objectTitle=EMA接受Somatrogon的市場營銷申請，以治療生長激素缺乏癥患兒, objectType=article, longId=207703, objectId=22ff20e70355, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22ff20e70355, replyNumber=0, likeNumber=91, createdTime=2021-12-03, rootId=0, userName=12498484m46(暫無昵稱), userId=7e622500011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22ff20e70355, moduleTitle=EMA接受Somatrogon的市場營銷申請，以治療生長激素缺乏癥患兒, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=22ff20e70355)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946200, encodeId=919d194620010, content=<a href='/topic/show?id=cbb816545ca' target=_blank style='color:#2F92EE;'>#somatrogon#</a>, objectTitle=長效生長激素Somatrogon治療生長激素缺乏癥兒童，日本3期臨床成功, objectType=article, longId=195624, objectId=fdb21956248b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdb21956248b, replyNumber=0, likeNumber=97, createdTime=2021-02-18, rootId=0, userName=12498484m46(暫無昵稱), userId=7e622500011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdb21956248b, moduleTitle=長效生長激素Somatrogon治療生長激素缺乏癥兒童，日本3期臨床成功, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fdb21956248b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1946199, encodeId=ba47194619965, content=<a href='/topic/show?id=cbb816545ca' target=_blank style='color:#2F92EE;'>#somatrogon#</a>, objectTitle=OPKO公司完成生長激素缺乏患兒（hGH-CTP）的Somatrogon全球III期研究的入組, objectType=article, longId=145945, objectId=022514594548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022514594548, replyNumber=0, likeNumber=81, createdTime=2019-07-18, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022514594548, moduleTitle=OPKO公司完成生長激素缺乏患兒（hGH-CTP）的Somatrogon全球III期研究的入組, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=022514594548)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
